[HTML][HTML] Current state of liver-directed therapies and combinatory approaches with systemic therapy in hepatocellular carcinoma (HCC)
P Viveiros, A Riaz, RJ Lewandowski, D Mahalingam - Cancers, 2019 - mdpi.com
The increasing set of liver-directed therapies (LDT) have become an integral part of
hepatocellular carcinoma (HCC) treatment. These range from percutaneous ablative …
hepatocellular carcinoma (HCC) treatment. These range from percutaneous ablative …
Current State of Liver-Directed Therapies and Combinatory Approaches with Systemic Therapy in Hepatocellular Carcinoma (HCC)
P Viveiros, A Riaz, RJ Lewandowski… - …, 2019 - pubmed.ncbi.nlm.nih.gov
The increasing set of liver-directed therapies (LDT) have become an integral part of
hepatocellular carcinoma (HCC) treatment. These range from percutaneous ablative …
hepatocellular carcinoma (HCC) treatment. These range from percutaneous ablative …
[PDF][PDF] Current State of Liver-Directed Therapies and Combinatory Approaches with Systemic Therapy in Hepatocellular Carcinoma (HCC)
P Viveiros, A Riaz, RJ Lewandowski, D Mahalingam - pdfs.semanticscholar.org
The increasing set of liver-directed therapies (LDT) have become an integral part of
hepatocellular carcinoma (HCC) treatment. These range from percutaneous ablative …
hepatocellular carcinoma (HCC) treatment. These range from percutaneous ablative …
Current state of liver-directed therapies and combinatory approaches with systemic therapy in hepatocellular carcinoma (HCC)
P Viveiros, A Riaz, RJ Lewandowski… - …, 2019 - scholars.northwestern.edu
The increasing set of liver-directed therapies (LDT) have become an integral part of
hepatocellular carcinoma (HCC) treatment. These range from percutaneous ablative …
hepatocellular carcinoma (HCC) treatment. These range from percutaneous ablative …
[HTML][HTML] Current State of Liver-Directed Therapies and Combinatory Approaches with Systemic Therapy in Hepatocellular Carcinoma (HCC)
P Viveiros, A Riaz, RJ Lewandowski, D Mahalingam - Cancers, 2019 - ncbi.nlm.nih.gov
The increasing set of liver-directed therapies (LDT) have become an integral part of
hepatocellular carcinoma (HCC) treatment. These range from percutaneous ablative …
hepatocellular carcinoma (HCC) treatment. These range from percutaneous ablative …
Current State of Liver-Directed Therapies and Combinatory Approaches with Systemic Therapy in Hepatocellular Carcinoma (HCC)
P Viveiros, A Riaz, RJ Lewandowski… - Cancers, 2019 - search.proquest.com
The increasing set of liver-directed therapies (LDT) have become an integral part of
hepatocellular carcinoma (HCC) treatment. These range from percutaneous ablative …
hepatocellular carcinoma (HCC) treatment. These range from percutaneous ablative …
Current State of Liver-Directed Therapies and Combinatory Approaches with Systemic Therapy in Hepatocellular Carcinoma (HCC).
P Viveiros, A Riaz, RJ Lewandowski… - …, 2019 - search.ebscohost.com
The increasing set of liver-directed therapies (LDT) have become an integral part of
hepatocellular carcinoma (HCC) treatment. These range from percutaneous ablative …
hepatocellular carcinoma (HCC) treatment. These range from percutaneous ablative …
[PDF][PDF] Current State of Liver-Directed Therapies and Combinatory Approaches with Systemic Therapy in Hepatocellular Carcinoma (HCC)
P Viveiros, A Riaz, RJ Lewandowski, D Mahalingam - academia.edu
The increasing set of liver-directed therapies (LDT) have become an integral part of
hepatocellular carcinoma (HCC) treatment. These range from percutaneous ablative …
hepatocellular carcinoma (HCC) treatment. These range from percutaneous ablative …
Current State of Liver-Directed Therapies and Combinatory Approaches with Systemic Therapy in Hepatocellular Carcinoma (HCC).
P Viveiros, A Riaz, RJ Lewandowski, D Mahalingam - Cancers, 2019 - europepmc.org
The increasing set of liver-directed therapies (LDT) have become an integral part of
hepatocellular carcinoma (HCC) treatment. These range from percutaneous ablative …
hepatocellular carcinoma (HCC) treatment. These range from percutaneous ablative …